Physician profile
Lauren Drotleff
NPI 1073855771
$3,619.97
in general payments reported to CMS, 2019-2025
21 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,231 · 2022: $1,117 · 2023: $645 · 2024: $457 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,220.31 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $821.09 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $384.94 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.99 | 2021-2023 | Jardiance |
| Abbott Laboratories | $192.77 | 2021-2024 | Mitraclip, Cardiomems |
| Pfizer INC. | $141.12 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $115.79 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $84.10 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $68.05 | 2021-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.55 | 2021-2022 | |
| Atricure, INC. | $45.33 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $40.12 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $37.92 | 2021-2022 | |
| Boston Scientific Corporation | $33.14 | 2021 | |
| Chiesi USA, INC. | $28.59 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $26.54 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $19.30 | 2023 | Zio Xt Patch |
| Alnylam Pharmaceuticals INC. | $18.54 | 2021 | |
| Amarin Pharma, INC. | $16.02 | 2022 | |
| Esperion Therapeutics, INC. | $14.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Drotleff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.